Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
europe
7
×
life sciences
7
×
europe blog main
national blog main
clinical trials
innovation
brexit
drugs
europe top stories
falsified medicines
labeling
mhra
regulations
uk
eli lilly
fda
national
national top stories
abbvie
alkermes
allergan
artificial intelligence
arvelle
biology
biotechnology
bms
boehringer ingelheim
boston blog main
boston top stories
bristol-myers squibb
buprenorphine
cambridge
cariprazine
disease
drug discovery
empagliflozin
european investment fund
felipe jain
financing
What
uk
brexit
charting
choppy
course
dynamic
end
medicines
period
plans
post
regulation
regulatory
reveals
transition
drug
fda
medicine
raised
alkermes
amsterdam
antipsychotic
approval
areas
based
benefits
bid
biotech
board
boehringer
bristol
cambridge
caveats
cell
closed
commonly
date
designed
development
diabetes
Language
unset
Current search:
europe
×
" life sciences "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@techcrunch.com
4 years ago
UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon
